APA (7th ed.) Citation

D, P., H, W., MA, B., K, M., G, D., A, B., . . . C, B. (2025). Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma. Cancer treatment and research communications, 43, 100939. https://doi.org/10.1016/j.ctarc.2025.100939

Chicago Style (17th ed.) Citation

D, Papakonstantinou, et al. "Molecular Analysis Highlights TREM2 as a Discriminating Biomarker for Patients Suffering from Pancreatic Ductal Adenocarcinoma." Cancer Treatment and Research Communications 43 (2025): 100939. https://doi.org/10.1016/j.ctarc.2025.100939.

MLA (9th ed.) Citation

D, Papakonstantinou, et al. "Molecular Analysis Highlights TREM2 as a Discriminating Biomarker for Patients Suffering from Pancreatic Ductal Adenocarcinoma." Cancer Treatment and Research Communications, vol. 43, 2025, p. 100939, https://doi.org/10.1016/j.ctarc.2025.100939.